BioSpace News Archive

BioMarin Pharmaceutical Inc. today announced that the Company presented positive results from a two-year analysis of the Phase 3 GENEr8-1 study.

In December 2021, imtmedical ag, a subsidiary of Vyaire Medical, initiated a voluntary field correction for certain bellavista™ ventilators.

When the Omicron variant first began to spread throughout the US, Premier Medical Laboratory Services (PMLS) identified one of the first cases in South Carolina through Next Generation Sequencing.

Imago BioSciences, Inc. announced that Hugh Y. Rienhoff, Jr., M.D., Imago’s Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 2022 Oncology Conference on Thursday, February 10, 2022 at 10:30 a.m. PT / 1:30 p.m. ET.

T2 Biosystems, Inc. a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to eighteen new employees.

Ardelyx, Inc. today announced that on February 1, 2022 , the compensation committee of the company’s board of directors granted four new non-executive employees.

Blueprint Medicines Corporation announced that, effective on February 1, 2022, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 26,212 shares of its common stock and an aggregate of 13,103 restricted stock units to fifteen new employees under Blueprint Medicines’ 2020 Inducement Plan.

Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Mont-Saint-Guibert, Belgium.

ImmunoGen, Inc. today announced that Susan Altschuller, Chief Financial Officer, and Anna Berkenblit, Chief Medical Officer, will participate in a fireside chat at the upcoming virtual SVB Leerink 11th Annual Global Healthcare Conference.

HeartFlow Holding, Inc. today announced that it and Longview Acquisition Corporation II (NYSE: LGV), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, have mutually agreed to terminate their previously announced business combination agreement, effective immediately, as a result of current unfavorable market conditions.